Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
The Anatomical Record
|
December 1, 1995
Ultrastructure and cytochemical staining characteristics of canine natural killer cells
D W Knapp, J J Turek, D B DeNicola, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
February 13, 2001
Prostaglandin E2 concentrations in naturally occurring canine cancer
S I Mohammed, K Coffman, N W Glickman, et al.
Journal of Veterinary Internal Medicine
|
February 21, 1998
Vincristine therapy for mast cell tumors in dogs
D L McCaw, M A Miller, P J Bergman, et al.
Veterinary and Comparative Oncology
|
January 13, 2012
Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer
T N Leach, M O Childress, S N Greene, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
April 6, 2004
Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer
S I Mohammed, K N M Khan, R S Sellers, et al.
Journal of Computer Assisted Tomography
|
April 8, 1998
The detection of pulmonary metastases by helical CT: a clinicopathologic study in dogs
D J Waters, F V Coakley, M D Cohen, et al.
Journal of Veterinary Internal Medicine
|
July 1, 1994
Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder
D W Knapp, R C Richardson, T C Chan, et al.
The Prostate
|
July 3, 1998
Workgroup I: rodent models of prostate cancer
M S Lucia, D G Bostwick, M Bosland, et al.
Cancer Research
|
December 3, 1999
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
S I Mohammed, D W Knapp, D G Bostwick, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2000
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer
D W Knapp, N W Glickman, W R Widmer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
The Anatomical Record
|
December 1, 1995
Ultrastructure and cytochemical staining characteristics of canine natural killer cells
D W Knapp, J J Turek, D B DeNicola, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
February 13, 2001
Prostaglandin E2 concentrations in naturally occurring canine cancer
S I Mohammed, K Coffman, N W Glickman, et al.
Journal of Veterinary Internal Medicine
|
February 21, 1998
Vincristine therapy for mast cell tumors in dogs
D L McCaw, M A Miller, P J Bergman, et al.
Veterinary and Comparative Oncology
|
January 13, 2012
Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer
T N Leach, M O Childress, S N Greene, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
April 6, 2004
Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer
S I Mohammed, K N M Khan, R S Sellers, et al.
Journal of Computer Assisted Tomography
|
April 8, 1998
The detection of pulmonary metastases by helical CT: a clinicopathologic study in dogs
D J Waters, F V Coakley, M D Cohen, et al.
Journal of Veterinary Internal Medicine
|
July 1, 1994
Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder
D W Knapp, R C Richardson, T C Chan, et al.
The Prostate
|
July 3, 1998
Workgroup I: rodent models of prostate cancer
M S Lucia, D G Bostwick, M Bosland, et al.
Cancer Research
|
December 3, 1999
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
S I Mohammed, D W Knapp, D G Bostwick, et al.
Cancer Chemotherapy and Pharmacology
|
October 6, 2000
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer
D W Knapp, N W Glickman, W R Widmer, et al.
Page
of 5